NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase
In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial
Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher
ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust
Clinton Seeks Cut In NIH Increase
Advisory Council To Be Named For Alternative Medicine Cuts
James Shannon, 89, Led NIH In 1960’s Period of Growth
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?









